Alo Hakeem, an Aleppo-based healthtech startup, has closed a $165,000 pre-seed round led by EBLA Ventures. Additional undisclosed investors also took part in the round. The funding will help the company expand its home healthcare platform across Syria ahead of a full app launch in November 2026.
What Alo Hakeem does
Founded in 2025 by Abdullatif Al-Baroudi and Albaraa Abdulsalam, Alo Hakeem runs a digital platform that connects patients with licensed home healthcare providers. Services include:
- Medical consultations
- Nursing
- Physiotherapy
- Elderly care
- Laboratory testing
- Diagnostic imaging
Today, the startup serves patients in Aleppo, Damascus and Hama.
How Alo Hakeem will use the funding
The pre-seed capital will go toward technology infrastructure, growth of the healthcare provider network and team expansion. In addition, the company will move from its current minimum viable product to a full mobile application. Public launch is scheduled for November 2026.
Alo Hakeem also plans to extend coverage to four additional Syrian governorates by the end of 2027.
Why the model matters
Home healthcare is a fragmented, trust-sensitive market. In many emerging markets, access and continuity of care have long depended on informal networks. Platforms like Alo Hakeem aim to replace that with a single booking and provider-matching layer.
That layer is as much a service-design challenge as a technology one. The platform has to standardise quality, trust and responsiveness across a dispersed network of independent providers.
Alo Hakeem by the numbers
- $165,000: pre-seed round led by EBLA Ventures
- 2025: year of founding
- 3: cities currently served (Aleppo, Damascus, Hama)
- 4: additional governorates targeted by end of 2027
- November 2026: planned launch of the full mobile app